- （InCROM CHINA）Is a Japanese InCROM (International Clinical Research Organization for Medicine, InCROM Group).
- InCROM founded in 1975, is a well-known Japanese CRO company has 37 years of history, specializing in clinical trials of new business for 29 years, in the industry ranked the top three. InCROM is headquartered in Osaka, with branch offices in Tokyo, Shanghai and China Hongkong and other major Chinese city, also has three specialized comprehensive hospital for clinical trials. As of 2019 December, the new drug clinical trials group to undertake the project amounted to more than 2000, involving the cardiovascular, respiratory, digestive, endocrine, infection, tumor, nerves, skin, facial features, rheumatology, Department of Hematology, surgery, urology and other professional fields.
(InCROM CHINA) was founded in 2004 February, the main development and clinical drug development a series of professional services, including: the phase I to IV clinical trial, human drug metabolism and pharmacokinetics, bioavailability study; randomized controlled trial; international multi center clinical trials of all kinds; clinical monitoring, project management, subjects were recruited, data management, biostatistics, medical translation, medical report writing, market research and product development strategy consulting; in addition to providing clinical trial service of medical devices and functional health products.
(InCROM CHINA) as the center in Shanghai, with offices in Beijing, Chengdu, Guangzhou, and a city with long-term stagnation monitors. Since the group in China set up a branch office, by virtue of the quality of clinical trials, the efficient integration of resources, high quality and good communication ability and professional and thoughtful service to win many sponsors favor, become one of the best Chinese domestic contract research organization of industry.
(InCROM CHINA) as the Shanghai City Pharmacological Society of clinical drug evaluation of professional committee chairman, has the great expert team, distribution in various clinical research unit and drug administration.
(InCROM CHINA) in collaboration with the sponsors, has come out in front of the multinational pharmaceutical company also has domestic top three large pharmaceutical group. The ongoing and completed projects a total of more than 100, a number of departments involved more than one hundred and fifty well-known hospital. (InCROM CHINA) based in China, facing the world, to carry out a comprehensive agency business global clinical study.